Stress system dynamics in childhood trauma-related depressio
- Conditions
- 10027946Depressionmood disorder
- Registration Number
- NL-OMON51711
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 120
General inclusion criteria:
- Mastery of Dutch language
- Age of >= 18 years
- Willingness and ability to give written informed consent
- Normal or corrected-to-normal vision
Additional inclusion criteria for the patient groups (i.e., MDD+CT and MDD-CT):
- Moderate to severe depression
- Score >= 26 on the Inventory of Depressive Symptoms-Self Report
(IDS-SR) (Rush et al., 2000)
- DSM-5 diagnosis of major depression disorder (MDD), confirmed with clinical
interview (MINI (Sheehan et al., 1997))
Additional inclusion criteria for the MDD+CT group:
- Moderate to severe childhood trauma (CT) before the age of 18
- Score above validated cut-off for moderate to severe CT using the
Childhood Trauma Questionnaire (CTQ) (Bernstein et al., 1994):
General exclusion criteria:
- Speech impairments
- Other lifetime severe psychiatric comorbidity (bipolar disorder, psychotic
disorder) or current alcohol/drug dependence
- Primary diagnosis of post-traumatic stress disorder (PTSD) or Acute Stress
Disorder (ASD)
- Lifetime diagnosis of borderline personality disorder (BPD)
- Any acute somatic or acute endocrine disease (e.g., acute asthma)
- Taking any medication known to influence endocrine systems
- Chronic benzodiazepine use (and sporadic use on the days of the lab visits)
- Neurological disorder
- Known contraindications for MRI investigations, such as the presence of metal
objects (e.g., pacemaker, arteriovenous clips) or severe claustrophobia.
Additional exclusion criteria for healthy controls and MDD-CT patients:
- Moderate to severe childhood trauma (CT) before the age of 18
- Score above validated cut-off for moderate to severe CT using CTQ
(see cutoff scores
above)
Additional exclusion criteria for healthy controls:
- Past or present psychiatric condition.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study parameters are the laboratory stress system dynamics measured by<br /><br>resting state brain function directly (0 - 40 minutes) and later (60-100<br /><br>minutes) after the stress (TSST) or control (placebo-TSST) test. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary study parameters are stress system dynamics measured through<br /><br>task-related fMRI activity and behavior, endocrine responses during stress,<br /><br>perceived stress and anxiety during stress, and (psycho)physiological<br /><br>responses, as well as daily life stress reactivity, including physiological and<br /><br>psychological measures, measured by ecological momentary and physiological<br /><br>assessment. </p><br>